Translational Medicine Postdoctoral Fellowship Grant

Translational Medicine Postdoctoral Fellowship Grant

Status: ACTIVE
Funder: Pharmaceutical Research And Manufacturers Of America Fnd Inc (PhRMA)
Amount: Up to US $120,000
Last Updated: March 03, 2026

Summary

The Translational Medicine Postdoctoral Fellowship by the PhRMA Foundation supports U.S. and non-U.S. citizens in multidisciplinary research training at accredited U.S. universities. The program aims to enhance credentials in translational medicine, focusing on turning laboratory observations into effective medical interventions. The fellowship includes a stipend of $60,000 per year for 12 to 24 months, promoting innovative research that addresses unmet clinical needs in various scientific disciplines.

Overview

NOTE: Application submission and reference letters of support are due by the deadline. PhRMA Foundation Mission The PhRMA Foundation is a 501(c)(3) nonprofit organization that fosters biopharmaceutical innovation and value-driven health care by investing in the frontiers of research. The Foundation catalyzes the careers of promising researchers through competitive, peer-reviewed grants and fellowships in the fields of drug delivery, drug discovery, translational medicine, and value assessment and health outcomes research. Vision A healthier world where all people have access to innovative, life-changing medicines. Values Integrity: We strive to be scientifically independent and evidence-based in our decision-making.Innovation: We invest in cutting-edge research and ideas that will improve patient health.Collaboration: We support collaborative research efforts that are diverse and inclusive. Translational Medicine Postdoctoral Fellowship The PhRMA Foundation’s Postdoctoral Fellowship in Translational Medicine supports individuals (U.S. and non-U.S. citizens) engaged in a multidisciplinary, collaborative research training program at an accredited U.S. university that will extend their credentials in translational medicine. Program Goals Translational medicine fosters a patient-focused research cycle that stretches from the lab bench to the patient bedside and back to the lab again. This includes adapting basic research discoveries in cells, tissues, and animals for application in humans and then taking the knowledge of what did and didn’t work in the clinic back to the bench. Given the breadth of the discipline, the PhRMA Foundation’s Translational Medicine Program focuses specifically on novel research that uses the “bedside to bench” approach to address unmet needs in the diagnosis, treatment, and prevention of disease. The Foundation seeks research proposals that focus on identifying unmet clinical needs and developing new diagnostic, experimental, and computational approaches and technologies to improve patient care and management. Applicants should work with clinical collaborators to identify unmet clinical needs. Proposals should integrate innovative technologies, with advanced biological, chemical, diagnostic, and pharmacological sciences and engineering methodologies in areas that include but not are limited to: Genetics (Molecular, Pharmaco-, Population, Medical)Genomics (Functional, Structural, Toxico-, Pharmaco-, Comparative)Systems (Biology and Pharmacology)Pathways and NetworksIntegrative BiologyModeling and SimulationTarget Identification and ValidationBiomarker Identification and ValidationMolecular EpidemiologyImagingDisease Modeling Funding The PhRMA Foundation Postdoctoral Fellowship in Translational Medicine provides $60,000 in stipend support per year for 12, 18, or 24 months. Funding is conditional upon the awardee’s continued employment with the university in the postdoctoral program, which will be assessed on a quarterly basis prior to payment. Payments will be made directly to the university on behalf of the awardee, with the understanding the university will administer the funds. This award is intended solely as a stipend and may not be used otherwise.

Eligibility

You can learn more about this opportunity by visiting the funder's website. Applicants (U.S. and non-U.S. citizens) must currently be in a PhD and/or MS degree-granting accredited U.S. university. Applicants must have a firm commitment from a research supervisor or sponsor at their university. Applicants must hold a PhD, PharmD, MD, or appropriate terminal research doctorate. If you do not hold one at the time of application submission, please state in your extended letter when you expect to receive it, as it must be received before funding can begin. Funding can begin as early as January 1, 2025, or as late as August 1, 2025.  Applicants who have taken leave from their career (e.g., parenting of a child, childbirth, long-term care of a parent/spouse/child/dependent, personal health issues) that puts them outside of the eligibility time frame can reach out to PhRMA Foundation staff ahead of their LOI submission to determine their eligibility. The Foundation aims to be flexible and adjust these time frames if appropriate.One of the objectives of this fellowship is to gain new skills and therefore an ideal candidate will be conducting their research in a new laboratory and not where their graduate work was performed. Only one postdoctoral applicant per lab may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their mentors and/or lab managers should decide who should apply.

Ineligibility

The Foundation will not consider multiple applications for the same or similar efforts on the same project. If multiple applicants are submitting proposed efforts on the same project, the efforts must be separate activities and not duplicative.You are not eligible if your doctoral degree was granted before January 1, 2022. PhRMA Foundation funds may not be used for tuition, fringe benefits, or indirect costs to the university.The Foundation will not consider multiple applications for similar efforts on the same project. For instance, if a predoc, postdoc, and faculty member from the same lab are all submitting applications for proposed efforts on the same project, the efforts must be separate activities and not duplicative.